Other OTC Pharmaceuticals (Pharmacies) - Paraguay

  • Paraguay
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$19.74m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 2.21%, resulting in a market volume of US$21.54m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.84 are generated in 2024.

Key regions: United Kingdom, Canada, France, Europe, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Paraguay is experiencing steady growth and development.

Customer preferences:
Paraguayan consumers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including the convenience and accessibility of these products. OTC medications are readily available in pharmacies across the country, allowing consumers to easily purchase them without the need for a prescription. Additionally, the affordability of these products compared to prescription medications makes them an attractive option for many Paraguayans.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Paraguay is the increasing demand for vitamins and dietary supplements. Paraguayans are becoming more health-conscious and are actively seeking ways to improve their overall well-being. As a result, there has been a surge in the consumption of vitamins and dietary supplements, which are readily available in pharmacies. This trend is expected to continue as consumers become more aware of the benefits of these products. Another trend in the market is the rising popularity of herbal and natural remedies. Paraguay has a rich tradition of using herbal medicines, and many consumers are turning to these remedies as an alternative to conventional pharmaceutical products. This trend is driven by a growing interest in natural and organic products, as well as a desire to reduce reliance on synthetic medications. Pharmacies in Paraguay are responding to this trend by expanding their offerings of herbal and natural remedies.

Local special circumstances:
Paraguay has a unique geographic location, being landlocked and surrounded by larger countries such as Brazil and Argentina. This has both advantages and disadvantages for the Other OTC Pharmaceuticals (Pharmacies) market. On one hand, the proximity to these larger markets allows for easy access to a wide range of products and suppliers. On the other hand, the landlocked nature of Paraguay can result in higher transportation costs, which can impact the prices of pharmaceutical products.

Underlying macroeconomic factors:
Paraguay has experienced stable economic growth in recent years, which has contributed to the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country has implemented policies to attract foreign investment and promote business growth, which has created a favorable environment for the pharmaceutical industry. Additionally, the increasing disposable income of Paraguayan consumers has allowed for greater spending on healthcare products, including OTC pharmaceuticals. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Paraguay is witnessing growth and development driven by customer preferences for convenience, affordability, and accessibility. The increasing demand for vitamins, dietary supplements, and herbal remedies reflects a growing health-consciousness among Paraguayans. The unique geographic location of Paraguay and stable macroeconomic factors also contribute to the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)